Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 2014-08-27 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 2019-03-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 2014-08-27 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 2023-03-30 |
Hyung Kim
BRD | Director/Board Member | 40 | 2024-03-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -3.00% | +2.27% | +77.60% | +109.33% | 73.96B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 64.66B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 27.86B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.32B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 19.98B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 17.84B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.3B | |
| Average | -1.92% | +7.62% | +59.94% | +196.82% | 31.9B | |
| Weighted average by Cap. | +0.68% | +8.75% | +59.25% | +158.22% |
Employees
-
